Bunge stock rating reiterated at Buy by UBS on biofuel outlook

Published 08/09/2025, 15:28
Bunge stock rating reiterated at Buy by UBS on biofuel outlook

Investing.com - UBS has reiterated its Buy rating and $100.00 price target on Bunge (NYSE:BG), currently trading at $83.66, following a management meeting at the firm’s Materials Conference. The prominent food products player, with a market capitalization of $16.75 billion, currently trades at an attractive P/E ratio of 8.28.

UBS analyst Manav Gupta noted that Bunge expects the final Renewable Volume Obligation (RVO) and a decision on Small Refinery Exemption (SRE) reallocations by December 2025. The company anticipates a favorable outcome as the Environmental Protection Agency and U.S. Department of Agriculture are working closely to protect farmer interests. InvestingPro data shows Bunge maintains strong financial metrics with a current ratio of 2.07, indicating solid liquidity to support its growth initiatives.

The analyst highlighted that the Indirect Land Use Change penalty for soybean oil has been dropped, improving its Carbon Intensity score and making it more competitive with alternative feedstocks like tallow and used cooking oil.

With foreign feeds receiving no production tax credit and only 50% of Renewable Identification Numbers, Bunge expects stronger demand for soybean oil to meet higher Renewable Volume Obligations in 2026 and 2027.

Bunge plans to provide updated 2025 earnings guidance that will incorporate Viterra, with re-segmentation likely to appear in third-quarter 2025 results, according to the UBS note. For deeper insights into Bunge’s financial health and growth prospects, including exclusive ProTips and comprehensive analysis, visit InvestingPro, where you’ll find detailed research reports covering 1,400+ top stocks.

In other recent news, Bunge Limited reported its Q2 2025 earnings, revealing a mixed financial performance. The company posted earnings per share of $1.31, surpassing analyst expectations of $1.14, marking a positive surprise of 14.91%. However, Bunge’s revenue of $9.17 billion fell short of the anticipated $12.46 billion, representing a significant revenue miss of 26.4%. Additionally, Bunge announced plans to raise $1.3 billion through a senior unsecured notes offering, consisting of two equal tranches due in 2030 and 2035.

Analyst activity around Bunge has been notable, with JPMorgan assuming coverage with an Overweight rating and a price target of $95, citing increased demand for soybean oil driven by U.S. biofuel policies. UBS also reiterated its Buy rating on Bunge, setting a price target of $100, maintaining a positive outlook on the company’s future. These recent developments highlight the varied investor sentiment and strategic moves surrounding Bunge.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.